Should hyperleptinemia eventually emerge as the main driving force of obesity-associated male hypogonadism, then future leptin sensitizers (currently being developed) might solve the obesity-induced testicular malfunction before weight loss occurs. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.